Secondary Sales and An Investor Covenant You Don't Want To Miss
If you're raising capital, investors will negotiate deal terms that affect more than just their payout. One particularly important—and often overlooked—investor right is how they treat secondary sales, which can have a dramatic impact on your ability to qualify for Qualified Small Business Stock (QSBS) treatment. This guide explains what secondary sales are, why they matter for QSBS eligibility, and what deal terms you need to protect.
What Are Secondary Sales?
A secondary sale is when an existing shareholder sells their shares to a new buyer. This is different from a primary offering, where the company itself issues new shares and receives the proceeds.
Example: Founders Joe and Sarah each own 50% of your startup, EarlyStage Inc. When a new investor comes in to raise $5 million, that could happen in two ways:
- Primary issuance: The company issues 1 million new shares to the investor in exchange for $5 million. Joe and Sarah still own their original shares, and the investor owns the new shares.
- Secondary sale: Joe sells 500,000 of his shares directly to the investor for $2.5 million. The company doesn't issue new shares; the investor simply buys from Joe's existing stake. Joe gets the cash, Sarah's ownership percentage increases (relatively), and the investor owns a piece of Joe's original stake.
In practice, most funding rounds involve both primary and secondary components. A typical Series A might be 80% primary (company issues new shares) and 20% secondary (founders or early employees sell some of their existing shares).
Why Secondary Sales Matter for QSBS
Here's where secondary sales become critical for your long-term tax planning: Section 1202 of the Internal Revenue Code allows eligible shareholders to exclude up to 100% of the gain from selling Qualified Small Business Stock (QSBS), subject to certain limits.
The Core Rule: QSBS Must Be Issued by the Company, Not Purchased from Another Shareholder
Section 1202 specifically requires that:
- You acquired the stock directly from the company (in an original issuance), not from another shareholder.
- You've held it for at least 5 years.
- The company meets certain criteria (C corporation, startup, etc.).
Secondary shares do not qualify under Section 1202. None of the gain is excluded. If an investor purchases shares in a secondary transaction, they can never get QSBS treatment on those shares, no matter how long they hold them.
Example: An investor purchases 1 million shares in a secondary transaction (from a founder) for $10 million when the company is worth $100 million. Five years later, when the company is worth $500 million, the investor sells all 1 million shares for $50 million. They have a $40 million gain. Because the shares were purchased secondarily, not issued by the company, Section 1202 doesn't apply. They owe long-term capital gains tax on the entire $40 million gain (likely 20% federal + state tax = $8+ million in tax). If they had received the shares in a primary issuance, they could exclude a significant portion of that gain.
How Secondary Sales Destroy Founder QSBS Eligibility
But the secondary sales issue isn't just about investors. It can destroy founder QSBS eligibility, too.
Here's a common scenario:
You and a cofounder own 1 million shares each (50% each). You raise a Series A, and the new investor demands the right to buy shares directly from the founders as part of the round. The investor buys 500,000 shares from you at the Series A price. Now your cap table looks like:
- You: 500,000 original shares + newly-issued shares you received as part of the round
- Cofounder: 1 million original shares
- Series A Investor: 500,000 shares purchased from you (secondary) + newly-issued shares
The investor's secondary shares will never qualify for QSBS. But here's the silent killer: if the Series A investor negotiated rights that allow them to force further secondary sales in the future, each future secondary round eats away at the company's ability to meet QSBS requirements.
Section 1202 contains an obscure but critical rule: if more than 50% of the company's gross assets consist of stock in other corporations (or other "passive" assets), the company does not qualify. Secondary sales themselves don't directly trigger this, but if secondary sales are frequent enough, they can indicate that the company is becoming more of a holding company than an operating business.
The Real Problem: Secondary Sales and Ownership Concentration
The bigger issue is this: secondary sales can be used to concentrate ownership in ways that damage later-stage fundraising and exit dynamics.
Imagine a founder who owns 1% of the company after early funding rounds. An investor comes in and wants to purchase a large secondary stake directly from this founder to increase their ownership. After the secondary sale, the founder owns even less (say, 0.5%), and the investor owns more. This dynamic—where secondary sales are used to shuffle shares between investors—can create cap table complexity that later investors find unattractive.
More importantly, if you're running a startup that's trying to maintain QSBS eligibility, frequent secondary sales signal that the cap table is being actively traded rather than being used to align founders and employees with the company's long-term success.
Key Deal Terms: What You Must Negotiate
Pro-Rata Rights
Pro-rata rights (or "pro-rata participation rights") allow existing investors to buy additional shares in future rounds to maintain their ownership percentage. This is standard in venture capital deals and is generally acceptable.
Why it matters for secondary sales: Pro-rata rights are a primary (not secondary) transaction. The company issues new shares to the investor as part of a future funding round. This doesn't damage QSBS eligibility because the investor is buying newly-issued shares, not purchasing from existing shareholders.
What to negotiate: Ensure that your pro-rata rights clause is clearly structured as primary issuance only. Don't allow the investor to exercise pro-rata rights by purchasing secondary shares from founders.
Rights of First Refusal (ROFR) and Co-Sale Rights
Rights of First Refusal give the company (or sometimes other investors) the right to purchase shares before an existing shareholder can sell them to a third party. Co-sale rights allow the investor to join in a secondary sale if a founder is selling.
Why it matters for secondary sales: ROFR can limit secondary sales by requiring the company to match external offers. If the company exercises its ROFR, it becomes a primary issuance (company buys the shares back) instead of a secondary sale. This protects QSBS eligibility.
What to negotiate: Insist on ROFR language that:
- Applies to any sale by founders or early employees to external parties.
- Allows the company (or a dedicated pool) to purchase the shares at the same price and terms offered by the external buyer.
- Is time-limited so it doesn't restrict founders indefinitely (many deals include ROFR for 5-7 years or until IPO).
Co-sale rights are less problematic, but ensure they don't become a vehicle for investors to engineer secondary transactions that damage your cap table.
The Section 4(a)(1½) Exemption (The Hidden Covenant)
Here's the covenant that many investors sneak into deal terms and founders miss: the Section 4(a)(1½) exemption.
Section 4(a)(1½) of the Securities Act provides an exemption from registration for resales of securities by certain affiliates and insiders. It's a registration law issue, not a tax issue. But it's highly relevant to secondary sales.
Why it matters: If an investor wants to do secondary transactions, they need to register the resale with the SEC (under Rule 144 or another exemption) or rely on an exemption like 4(a)(1½). Some investors insist on explicit language in the company's governance documents that allows resales under 4(a)(1½).
What founders should know: Don't agree to language that automatically grants all investors the right to resell under 4(a)(1½). This becomes a back door to secondary sales.
What to negotiate: If investors want resale rights, negotiate specific limits:
- Resales are only allowed after a certain liquidity event (IPO, acquisition) or after a specified holding period.
- The company retains a right to repurchase resold shares at fair market value before they're sold to a third party.
- Any secondary sales are subject to QSBS preservation covenants (see below).
QSBS Preservation Covenants: The Deal Term You Need
If you're serious about preserving QSBS eligibility for founders and early employees, insert a specific covenant into your investor agreements that restricts secondary sales that could jeopardize QSBS qualification.
Example QSBS preservation covenant:
"The Company shall not, and shall not permit any shareholder to, engage in secondary sales (resales by shareholders to third parties) that would:
- (a) Cause the Company to fail to meet the requirement that no more than 50% of gross assets are investment securities (Section 1202(c)(1)(B));
- (b) Involve the sale of founder or employee shares at prices that would materially impair the QSBS holding period requirements; or
- (c) Create a pattern of secondary sales that indicates the Company is being used as a holding company rather than an operating business."
This is a mouthful, but the idea is simple: secondary sales shouldn't undermine the company's status as a legitimate operating business eligible for QSBS treatment.
Practical Examples: How Secondary Sales Damage QSBS
Example 1: The Investor Secondary in Series A
Facts: You're raising a Series A for $10 million. The investor wants $8 million in primary shares and $2 million of secondary from founders. The founders are happy to diversify.
QSBS Impact: The $2 million of secondary shares have zero QSBS value for the investor. If the investor holds those shares for 5+ years and sells them in an exit, they owe full capital gains tax on the $2 million investment plus any gain. That's $400,000+ in unnecessary taxes (at 20%+ rates).
The real damage: The founders who sold secondary shares just reduced the size of their original shareholdings. If they were counting on QSBS treatment for 100% of their shares, they've now carved out a portion that doesn't qualify. The tax planning is muddled.
How to prevent it: Negotiate with the investor upfront: we'll do $10 million primary, and if you want to buy founder shares, we'll structure it as a separate secondary transaction after the Series A closes. That way, the Series A remains pure primary, preserving QSBS clarity.
Example 2: The Board Member Secondary
Facts: You bring on a board member from a Fortune 500 company who wants equity. She negotiates for 1% of the company in exchange for her board service. The CEO agrees to grant her options, but those options have a secondary component: the company agrees that she can sell 50% of her shares to investors in the next funding round.
QSBS Impact: The board member's 50% holding will never qualify for QSBS because those shares are being sourced from founders (not newly issued by the company). If the company has a successful exit, the board member will owe capital gains tax on the full gain from those secondary shares.
How to prevent it: If you're giving equity to a board member, keep it simple: grant them options as an employee if they're providing services, or grant them restricted stock if they're a non-employee director. Don't embed secondary sale rights into the grant agreement.
Example 3: The Management Secondary Pool
Facts: You're raising a Series B with a new lead investor. That investor wants to acquire a 10% management secondary—meaning founders and early employees will sell $5 million worth of shares directly to the new investor. The company isn't selling any new shares in this transaction; it's all coming from existing shareholders.
QSBS Impact: This is a pure secondary transaction. $5 million of founder/employee shares are being transferred to an investor. None of that $5 million represents newly-issued shares from the company. Those shares will never qualify for QSBS treatment going forward.
How to prevent it: Negotiate that any new investor stake be achieved through primary issuance (the company issues shares) rather than secondary purchases from existing shareholders. If the new investor insists on a secondary component, cap it strictly and require that QSBS preservation covenants apply.
How to Structure Secondary Transactions Properly
If you do need to allow secondary sales (many mature startups do), structure them to minimize QSBS damage:
Use a Tender Offer Mechanism
Instead of allowing investors to directly purchase secondary shares from founders, use a company-administered tender offer:
- The company invites shareholders (founders, employees) to offer shares for sale at a stated price.
- The company repurchases those shares.
- The company then resells those shares to new investors.
This converts what looks like a secondary transaction into a primary one for QSBS purposes. The company is the intermediary.
Grandfather Founder Shares
If you're doing a secondary sale that includes founder shares, explicitly carve out an exception: founder shares from before the secondary round are not included. Only later-issued options or restricted stock are eligible for secondary sale.
Time-Limit Secondary Sales
Restrict secondary sales to specific windows or only for specific purposes (e.g., founder liquidity events, exits). Don't allow continuous secondary trading.
The Bottom Line
Secondary sales are a normal part of venture capital financing, but they come with a hidden cost: they destroy QSBS eligibility for the shares being sold. If you're building a startup that you intend to hold long-term, QSBS treatment could save you millions in taxes on an exit. That means protecting your cap table from unnecessary secondary sales.
When investors ask for secondary rights, ask them why. Is it for liquidity? Can you accommodate that through primary issuance instead? Is it for control or ownership adjustments? Structure it more carefully. And always insist on explicit QSBS preservation covenants in any deal with secondary components.
A few minutes of negotiation on deal terms can protect years of tax benefits. It's worth the effort.
Related Reading
For more on startup fundraising and securities law, see our Complete Guide to Regulation D, Rule 506(b) vs. 506(c) Comparison, and Accredited Investor Rules.
